Handa filings that have been approved by U.S. FDA include:

 

● Dexlansoprazole Delayed-Release Capsules (Par Pharmaceutical)
● Quetiapine Fumarate Extended-Release Tablets (Par Pharmaceutical)
● TASCENSO ODT (Cycle Pharmaceuticals)

Handa filings that have been approved by Health Canada include:

● Quetiapine Fumarate Extended-Release Tablets (ANDS in Partner’s name)